Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, Via Festa del Perdono 7, 20122, Milan, Italy.
Department of Clinical-Surgical Diagnostic and Pediatric Sciences, Università degli Studi di Pavia, Pavia, Italy.
Eur Radiol. 2017 Oct;27(10):4372-4378. doi: 10.1007/s00330-017-4810-3. Epub 2017 Mar 29.
To investigate whether there is an increased signal intensity (SI) of dentate nucleus (DN) and globus pallidus (GP) on unenhanced T1-weighted magnetic resonance imaging (MRI), in patients who had undergone multiple administrations of gadoxetate disodium.
We retrospectevely included stage III melanoma patients, who had been previously enrolled in a trial of adjuvant therapy and who had undergone whole-body contrast-enhanced MRIs with gadoxetate disodium every three months for their follow-up. The SI ratios of DN-to-pons and GP-to-thalamus on unenhanced T1-weighted images were calculated. The difference in SI ratios between the first and the last MRI examinations was assessed and a linear mixed model was performed to detect how SI ratios varied with the number of administrations.
Eighteen patients were included in our study. The number of gadoxetate disodium administrations ranged from 2 to 18. Paired t-test did not show any significant difference in DN-to-pons (p=0.21) and GP-to-thalamus (p=0.09) SI ratios by the end of the study. DN-to-pons SI ratio and GP-to-thalamus SI ratio did not significantly increase with increasing the number of administrations (p=0.14 and p=0.06, respectively).
Multiple administrations of gadoxetate disodium are not associated with increased SI in DN and GP in the brain.
• Gadolinium may deposit in the human brain after multiple GBCA administrations. • Gadolinium deposition is associated with increased T1W signal intensity • Increase in signal intensity is most apparent within the DN and GP • Multiple administrations of gadoxetate disodium do not increase T1W signal.
探讨多次钆塞酸二钠给药后,未增强 T1 加权磁共振成像(MRI)中齿状核(DN)和苍白球(GP)信号强度(SI)是否增加。
我们回顾性纳入了 III 期黑色素瘤患者,这些患者之前参加了辅助治疗试验,并在随访期间每 3 个月进行一次全身对比增强 MRI 检查,使用钆塞酸二钠。计算未增强 T1 加权图像上 DN 与脑桥和 GP 与丘脑的 SI 比值。评估首次和末次 MRI 检查之间 SI 比值的差异,并采用线性混合模型来检测 SI 比值如何随给药次数而变化。
本研究共纳入 18 例患者。钆塞酸二钠给药次数范围为 2 至 18 次。配对 t 检验显示,研究结束时 DN 与脑桥(p=0.21)和 GP 与丘脑(p=0.09)的 SI 比值无显著差异。DN 与脑桥 SI 比值和 GP 与丘脑 SI 比值随给药次数的增加均无显著增加(p=0.14 和 p=0.06)。
多次给予钆塞酸二钠与脑内 DN 和 GP 的 SI 增加无关。
多次 GBCA 给药后,钆可能会在人脑内沉积。
钆沉积与 T1W 信号强度增加有关。
信号强度增加最明显的是在 DN 和 GP 内。
多次给予钆塞酸二钠不会增加 T1W 信号。